| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.2M | +22.4% |
| SG&A Expense | $6.0M | +4.3% |
| Operating Income | -$18.6M | +52.2% |
| Interest Expense | -$640K | — |
| Net Income | -$18.0M | +53.7% |
| EPS (Basic) | -$1.87 | +60.8% |
| EPS (Diluted) | -$1.87 | +60.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.4M | -29.2% |
| Current Assets | $29.1M | -27.6% |
| Total Assets | $31.3M | -23.5% |
| Current Liabilities | $3.3M | +168.3% |
| Total Liabilities | $4.9M | +283.0% |
| Stockholders' Equity | $26.4M | -33.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.7M | +31.6% |
| Capital Expenditures | $118K | +59.5% |
| Investing Cash Flow | -$118K | -59.5% |
| Financing Cash Flow | $4.0M | — |
| Free Cash Flow | -$14.8M | +31.3% |